CHAU T DANG

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NEW YORK, NY NPI 1861422982

General Payments — all program years on this page

$113,889.23

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 104
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,046.14 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Daiichi Sankyo Inc. $1,712.501
NOVARTIS PHARMACEUTICALS CORPORATION $1,350.001
Acerta Pharma LLC $841.456
Genentech USA, Inc. $142.191

By program year

Program yearAmountRecords
2018 $5,866.155
2019 $28,581.5329
2020 $11,491.9010
2021 $14,489.8814
2022 $16,716.1817
2023 $32,697.4520
2024 $4,046.149

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086954909 Novartis Pharmaceuticals Corporation $1,350.00 01/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089412982 Daiichi Sankyo Inc. $1,712.50 01/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104252577 AstraZeneca Pharmaceuticals LP $13.08 04/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1104255041 AstraZeneca Pharmaceuticals LP $48.09 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104573492 AstraZeneca Pharmaceuticals LP $500.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104590832 AstraZeneca Pharmaceuticals LP $185.87 04/12/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 View at CMS
1104710659 AstraZeneca Pharmaceuticals LP $58.50 02/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105237224 AstraZeneca Pharmaceuticals LP $35.91 06/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132987276 Genentech USA, Inc. $142.19 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.